Cite
Harvey AJ, Avery TD, Schaeffer L, et al. Discovery of BNC375, a Potent, Selective, and Orally Available Type I Positive Allosteric Modulator of α7 nAChRs. ACS Med Chem Lett. 2019;10(5):754-760doi: 10.1021/acsmedchemlett.9b00001.
Harvey, A. J., Avery, T. D., Schaeffer, L., Joseph, C., Huff, B. C., Singh, R., Morice, C., Giethlen, B., Grishin, A. A., Coles, C. J., Kolesik, P., Wagner, S., Andriambeloson, E., Huyard, B., Poiraud, E., Paul, D., & O'Connor, S. M. (2019). Discovery of BNC375, a Potent, Selective, and Orally Available Type I Positive Allosteric Modulator of α7 nAChRs. ACS medicinal chemistry letters, 10(5), 754-760. https://doi.org/10.1021/acsmedchemlett.9b00001
Harvey, Andrew J, et al. "Discovery of BNC375, a Potent, Selective, and Orally Available Type I Positive Allosteric Modulator of α7 nAChRs." ACS medicinal chemistry letters vol. 10,5 (2019): 754-760. doi: https://doi.org/10.1021/acsmedchemlett.9b00001
Harvey AJ, Avery TD, Schaeffer L, Joseph C, Huff BC, Singh R, Morice C, Giethlen B, Grishin AA, Coles CJ, Kolesik P, Wagner S, Andriambeloson E, Huyard B, Poiraud E, Paul D, O'Connor SM. Discovery of BNC375, a Potent, Selective, and Orally Available Type I Positive Allosteric Modulator of α7 nAChRs. ACS Med Chem Lett. 2019 Mar 25;10(5):754-760. doi: 10.1021/acsmedchemlett.9b00001. eCollection 2019 May 09. PMID: 31097995; PMCID: PMC6511964.
Copy
Download .nbib